Patents by Inventor Edward E. Jacobs, Jr.

Edward E. Jacobs, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7267817
    Abstract: A method of treatment of a patient includes administering to the patient stored red blood cells and a hemoglobin solution. The stored red blood cells and the hemoglobin solution can be administered to the patient simultaneously. Alternatively, the hemoglobin solution can be administered to the patient prior to administrating the stored red blood cells or the stored red blood cells can be administered to the patient prior to administering the hemoglobin solution. A composition of the invention includes stored red blood cells and a hemoglobin solution.
    Type: Grant
    Filed: October 18, 2004
    Date of Patent: September 11, 2007
    Assignee: Biopure Corporation
    Inventors: Thomas C. Page, William R. Light, Edward E. Jacobs, Jr.
  • Patent number: 6811778
    Abstract: A method of treatment of a patient includes administering to the patient stored red blood cells and a hemoglobin solution. The stored red blood cells and the hemoglobin solution can be administered to the patient simultaneously. Alternatively, the hemoglobin solution can be administered to the patient prior to administrating the stored red blood cells or the stored red blood cells can be administered to the patient prior to administering the hemoglobin solution. A composition of the invention includes stored red blood cells and a hemoglobin solution.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: November 2, 2004
    Assignee: Biopure Corporation
    Inventors: Thomas C. Page, William R. Light, Edward E. Jacobs, Jr.
  • Patent number: 6541449
    Abstract: The present invention relates to a method of therapeutically, or prophylactically, treating a vertebrate to increase tissue oxygenation, or maintain issue oxygenation, in tissue of a vertebrate wherein the tissue has a reduced red blood cell flow, and wherein the vertebrate has a normovolemic blood volume and at least a normal systemic vascular resistance. The method comprises introducing into the circulatory system of the vertebrate at least one dose of hemoglobin.
    Type: Grant
    Filed: December 26, 2000
    Date of Patent: April 1, 2003
    Assignee: Biopure Corporation
    Inventors: Edward E. Jacobs, Jr., Carl W. Rausch
  • Patent number: 5854209
    Abstract: The present invention relates to a method of therapeutically, or prophylactically, treating a vertebrate to increase tissue oxygenation, or maintain issue oxygenation, in tissue of a vertebrate wherein the tissue has a reduced red blood cell flow, and wherein the vertebrate has a normovolemic blood volume and at least a normal systemic vascular resistance. The method comprises introducing into the circulatory system of the vertebrate at least one dose of hemoglobin.
    Type: Grant
    Filed: March 23, 1995
    Date of Patent: December 29, 1998
    Assignee: Biopure Corporation
    Inventors: Edward E. Jacobs, Jr., Carl W. Rausch